Old Web
English
Sign In
Acemap
>
authorDetail
>
M. Snyder
M. Snyder
Pfizer
Tofacitinib
Physical therapy
Internal medicine
Medicine
Rheumatoid arthritis
4
Papers
12
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Re-establishment of efficacy of tofacitinib, an oral JAK inhibitor, after temporary discontinuation in patients with rheumatoid arthritis
2020
Clinical Rheumatology
Jeffrey L. Kaine
John Tesser
L. Takiya
Ryan DeMasi
Lisy Wang
M. Snyder
Koshika Soma
Haiyun Fan
Vara Bandi
Jürgen Wollenhaupt
Show All
Source
Cite
Save
Citations (4)
OP0037 Efficacy of tofacitinib after temporary discontinuation in patients with rheumatoid arthritis: analysis of data from open-label long-term extension studies
2018
Annals of the Rheumatic Diseases
J. Kaine
J Tesser
Ryan DeMasi
L. Takiya
Lisy Wang
M. Snyder
Haiyun Fan
V. Bandi
J. Wollenhaupt
Show All
Source
Cite
Save
Citations (2)
THU0193 Reestablishment of efficacy of tofacitinib, an oral janus kinase inhibitor, in rheumatoid arthritis patients after temporary discontinuation
2017
Annals of the Rheumatic Diseases
J. Kaine
J Tesser
Ryan DeMasi
L. Takiya
Lisy Wang
M. Snyder
Haiyun Fan
J. Wollenhaupt
Show All
Source
Cite
Save
Citations (3)
1